Delivery Order SPE2DB24D2010-SPE2DB25FAAKQ
- Not listed
- This is a $23,017.73 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Myrbetriq ER 50 mg tablets. The contract has an ultimate completion date of May 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs...
- The Defense Logistics Agency awarded a delivery order valued at $8,784.72 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,881.13 firm fixed-price delivery order is for the supply of the drug Myrbetriq ER 50 mg tablets. The contract has a completion date of December 27, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Myrbetriq ER 25 mg tablets. The $12,672.39 firm fixed-price contract has a completion date of May 12, 2025 and is not set aside. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,350.57, is for the supply of Myrbetriq ER 50 MG tablets. The order has an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
- This is a $11,857.03 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Myrbetriq ER 25 mg tablets, with a performance period through May 8, 2023. This award is part of AmerisourceBergen's broader $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Myrbetriq ER 50 mg tablets. The contract, valued at $68,843.04, has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $8,135.26 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of MYRBETRIQ ER 25 MG TABLET 90S. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which has a total potential value of up to $999,999,999.00 and runs through December 31, 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $17,473.78 delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,558,896,522 units of the prescription drug Myrbetriq ER 25 mg tablets. This delivery order, which has a completion date of October 27, 2022, is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical to supply a comprehensive range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,537.51 firm fixed-price contract is for the delivery of Myrbetriq ER 25 mg tablets. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAAKQDelivery Order
The Defense Logistics Agency awarded a $25,044.82 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. As a prime vendor under the DLA Troop Support Medical IDC, the company supplies a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs globally. The Myrbetriq delivery represents a routine pharmaceutical supply fulfillment within AmerisourceBergen's extensive federal contract portfolio with DLA, demonstrating the company's ongoing role as a critical supplier of brand-name and generic medications to the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.0k | 7/18/25 |